The Ministry of Health Commission approved the inclusion of two Biocad drugs in the list of vitally important
At a meeting today, February 8, the profile commission of the Ministry of Health approved the inclusion of two Biocad...
At a meeting today, February 8, the profile commission of the Ministry of Health approved the inclusion of two Biocad...
Biocad, which is unable to include its drugs for the treatment of multiple sclerosis in the lists of vital and...
After industry associations of the pharmaceutical industry failed to get the government to include new drugs in the list of...
While international pharmaceutical manufacturers have noticeably reduced clinical trials of drugs in Russia, the R-Pharm company founded by Alexey Repik...
The emergence of a large number of generics of lenalidomide for the treatment of multiple myeloma instead of the original...